InsidersTradesSigma
툴젠 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 툴젠 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 툴젠 has published 58 insider filings. Market capitalisation: €314.4bn. The latest transaction was disclosed on 8 July 2026 (Other). Among the most active insiders: 한지학. Every trade is free.
58
Insider Decl.
0
Thresholds
·
11 ops.
Buy Volume
·
1 ops.
Sell Volume
21Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,758 of 25,750 companies
33.3
score / 100
Value17
Quality49
FCF yld-6.8%
Earn yld-12%
EV/EBITDA·
ROE-69%
Gross mgn87%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 July 2026
Declarations58 total
25 of 58 declarations
About 툴젠
툴젠 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing genome editing technologies.